201 results on '"Lencioni M"'
Search Results
2. Cardiac resynchronization therapy using endocardial versus trans-coronary sinus, epicardial left ventricular pacing: the Epi-Endo study
3. Cardiac resynchronization therapy using endocardial versus trans-coronary sinus, epicardial left ventricular pacing: the Epi-Endo study
4. Meta-analysis on clinical utility of oesophageal temperature monitoring in AF ablation
5. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
6. PD-022 FOLFOXIRI as primary treatment for locally advanced unresectable pancreatic cancer (LAPC): a prospective study
7. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
8. Myocardial fibrosis as a predictor of sudden death in patients with coronary artery disease
9. Grayzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction greater than 35%
10. Not only chemotherapy in the second-line treatment of metastatic gastric cancer
11. P-188 Safety and efficacy of first-line gemcitabine plus nab-paclitaxel for elderly metastatic pancreatic cancer patients
12. P-219 Clear cell variant of hepatocellular carcinoma (HCC-CC): A single-center observational study of an uncommon subtype
13. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience
14. Activity of second-line chemotherapy after first-line FOLFOXIRI in metastatic colorectal cancer (MCRC) patients (pts): Updated results of a phase-I-II study: 1285
15. 48-stündige Dauerinfusion mit Irinotecan (CPT-11), Oxaliplatin (L-OHP), Leucovorin (LV) und 5-Fluorouracil (5-FU) in 2-wöchentlichen Abständen bei Patienten mit metastasierendem kolorektalem Karzinom (KRK): 539
16. PHASE I—II STUDY OF IRINOTECAN (CPT-11), OXALIPLATIN (LOHP), LEUCOVORIN (LV) AND 5-FLUOROURACIL (5-FU) 48-HOUR CONTINUOUS INFUSION (C.I.) IN METASTATIC COLORECTAL CANCER PATIENTS: Abstract 1161
17. SEMI-INTERMITTENT 48 HOURS INFUSION 5-FLUOROURACIL (5-FU), ASSOCIATED WITH LEUCOVORIN (LED), EPIRUBICIN (EPIDX) AND CISPLATIN (CDDP) IN METASTATIC GASTRIC CARCINOMA (MGC): A PHASE II STUDY.
18. Impact of Re-usable surgical drapes on perioperative wound and systemic infections
19. Characterization of mismatch repair deficiency in biliary tract cancer
20. Baseline computed-tomography (CT)-evaluated sarcopenia predicts toxicity from first-line chemotherapy in metastatic gastric cancer (mGC) patients
21. Longitudinal evaluation of angiogenesis-related circulating biomarkers during second-line treatment with paclitaxel and ramucirumab in advanced gastroesophageal cancer
22. Urine culture, asymptomatic bacteriuria and diabetic patients. Is antibiotic prophylaxis always indicated?
23. Prostate cancer diagnosis report to the patient may induce subjective urinary and sexual symptoms worsening
24. Analysis of early tumor shrinkage and depth of response in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX or gemcitabine + nab-paclitaxel
25. Primary Retroperitoneal Müllerian Adenocarcinoma: A Case Report and Literature Review
26. Analysis of DPYD and UGT1A1 genotype in patients with advanced pancreatic cancer treated with modified FOLFIRINOX
27. SC201 - Impact of Re-usable surgical drapes on perioperative wound and systemic infections
28. P-319 - Longitudinal evaluation of angiogenesis-related circulating biomarkers during second-line treatment with paclitaxel and ramucirumab in advanced gastroesophageal cancer
29. P-299 - Baseline computed-tomography (CT)-evaluated sarcopenia predicts toxicity from first-line chemotherapy in metastatic gastric cancer (mGC) patients
30. P-279 - Characterization of mismatch repair deficiency in biliary tract cancer
31. ORAL ABSTRACTS (2)EP & Ablation19CARDIAC ABLATION PATIENT REPORTED OUTCOMES MEASURES (PROMS): ANALYSIS OF POST-ABLATION AND 1 YEAR FOLLOW-UP DATA20INTENTIONAL CORONARY VEIN EXIT AND CARBON DIOXIDE INSUFFLATION TO ALLOW SAFE SUBXIPHOID EPICARDIAL ACCESS FOR VENTRICULAR MAPPING AND ABLATION - FIRST EXPERIENCE21PACED FRACTIONATION DETECTION AS A TOOL FOR MAPPING SCARS IN VT22DOES USE OF CONTACT-FORCE SENSING CATHETERS IMPROVE THE OUTCOME OF ABLATION OF VENTRICULAR TACHYCARDIA?23RETROGRADE AORTIC ACCESS OF THE PULMONARY VENOUS ATRIUM PROVIDES EQUIVALENT OUTCOMES TO RIGHT ATRIAL OR TRANSEPTAL ACCESS OF THE LEFT ATRIUM IN PATIENTS WITH CONGENITAL HEART DISEASE24COMPUTATIONAL THREE-DIMENSION LEFT ATRIAL APPENDAGE WALL THICKNESS MAPS AND HISTOLOGICAL ANALYSIS TO GUIDE LEFT ATRIAL APPENDAGE ELECTRICAL ISOLATIONPacing & Devices25IDENTIFYING THE OPTIMAL LOCATION FOR LV ENDOCARIDAL PACING:RESULTS FROM A MULTICENTRE INTERNATIONAL REGISTRY OF LV ENDOCARDIAL PACING26UK MULTI-CENTRE REGISTRY OF TRANSVENOUS LEAD EXTRACTION: CLINICAL OUTCOME USING TRACTION, CUTTING SHEATHS AND LASER TECHNIQUES27SKIN FISTULA FORMATION - A NEW EXPERIENCE WITH THE NEW TYRX ABSORBABLE ANTIMICROVIAL ENVELOPE28BIFOCAL RIGHT VENTRICULAR PACING IN PATIENTS WITH FAILED CORONARY-SINUS LEAD IMPLANTS: LONG-TERM RESULTS FROM MULTICENTRE REGISTRY29REAL TIME X-MRI GUIDED LEFT VENTRICULAR LEAD IMPLANTATION FOR TARGETED DELIVERY OF CARDIAC RESYNCHRONIZATION THERAPY30ACUTE AND CHRONIC PERFORMANCE OF COMMUNICATING LEADLESS ANTI-TACHYCARDIA PACEMAKER AND SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR
32. Prognostic value of the neutrophil-to-lymphocyte ratio in advanced hepatocellular carcinoma: An exploratory analysis from the ARQ197-215 study
33. Prognostic significance of the neutrophil-to-lymphocyte ratio in patients with advanced hepatocellular carcinoma: the ARQ197-215 study
34. Impact on Survival of Timing and Duration of Adjuvant Chemotherapy in Radically Resected Gastric Cancer
35. P102 - Prostate cancer diagnosis report to the patient may induce subjective urinary and sexual symptoms worsening
36. P36 - Urine culture, asymptomatic bacteriuria and diabetic patients. Is antibiotic prophylaxis always indicated?
37. P-159 - Analysis of early tumor shrinkage and depth of response in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX or gemcitabine + nab-paclitaxel
38. Fixed-dose rate gemcitabine plus capecitabine: a second-line option for metastatic pancreatic cancer patients pretreated with oxaliplatin
39. Role of adjuvant chemotherapy in the treatment of radically resected biliary tract cancer: a single institution experience
40. Folfiri as third-line treatment in metastatic gastric cancer
41. Patient Reported Outcomes Measures (PROMs) in Cardiac Ablation Patients – a NICE Commissioned Pilot
42. Second-line chemotherapy after disease progression following first-line FOLFOXIRI in advanced pancreatic cancer patients
43. Tolerability of FOLFOXIRI regimen after surgical resection for pancreatic cancer
44. Palliative gastrectomy in asymptomatic metastatic esophagogastric cancer (EGC): does it make sense?
45. Prognostic model for patients (pts) with advanced pancreatic cancer (aPC) receiving first-line modified FOLFIRINOX (mFOLFIRINOX)
46. Single-centre experience with third-line chemotherapy with irinotecan plus 5-fluorouracil and leucovorin (FOLFIRI) in metastatic gastric cancer patients
47. Devices & Sudden death31Quadripolar left ventricular leads should be the gold standard in crt due to efficacy and cost effectiveness: an analysis from a multi-centre uk registry32Cardiac computed tomography is a feasible imaging modality for pre procedural planning in patients undergoing upgrade from pacemakers to CRT33Derivation and external validation of a cardiac resynchronization therapy response score34Generation and validation of transformation coefficients to reconstruct 12-lead electrocardiograms from 3 subcutaneous implantable cardioverter defibrillator electrodes35Risk stratification of sudden cardiac death: positive evaluation of novel surface electrocardiogram biomarkers in a brugada syndrome cohort36The real world cost of cardiac implantable electronic device transvenous extractions37Advances in technology for rapid and reliable ecg acquisition38Excellent symptom rhythm correlation in patients with palpitations using a novel smartphone based event recorder39Differential ventricular repolarisation responses during sympathetic surge versus sustained sympathetic stimulation–in vivo evidence from humans40Approaching a fluro free daily life ep lab41Development and validation of the cardiff cardiac ablation prom (C-CAP) for patients with symptomatic cardiac arrhythmias42The changing tide of novel oral anti-coagulant use in england
48. 2372 Is there a role for palliative gastrectomy in asymptomatic metastatic gastric cancer?
49. 2362 Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients
50. P-180 Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients: a single institution retrospective cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.